Impact of pretreatment tumor growth rate on outcome of early-stage lung cancer treated with stereotactic body radiation therapy

International Journal of Radiation Oncology Biology Physics

Volumn 89, Issue 3, 2014, Pages 532-538

  Atallah, Soha ^a   Cho, B C John ^a   Allibhai, Zishan ^a   Taremi, Mojgan ^a   Giuliani, Meredith ^a   Le, Lisa W ^a   Brade, Anthony ^a   Sun, Alexander ^a   Bezjak, Andrea ^a   Hope, Andrew J ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; DIAGNOSIS; DISEASES; GROWTH RATE; RADIOTHERAPY; REGRESSION ANALYSIS; TUMORS;

COX PROPORTIONAL HAZARD MODEL; COX REGRESSION ANALYSIS; EARLY-STAGE LUNG CANCERS; EASTERN COOPERATIVE ONCOLOGY GROUP; FAILURE-FREE SURVIVAL; MULTI VARIATE ANALYSIS; NON SMALL CELL LUNG CANCER; STEREOTACTIC BODY RADIATION THERAPY;

COMPUTERIZED TOMOGRAPHY;

ADULT; AGED; ARTICLE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; STEREOTACTIC BODY RADIATION THERAPY; TUMOR GROWTH;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; FOUR-DIMENSIONAL COMPUTED TOMOGRAPHY; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PREOPERATIVE PERIOD; PROPORTIONAL HAZARDS MODELS; RADIOSURGERY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84902117796     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.03.003     Document Type: Article

References (20)

1. H. Onishi, H. Shirato, and Y. Nagata et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study J Thorac Oncol 2 2007 S94 S100
2. M. Taremi, A. Hope, and M. Dahele et al. Stereotactic body radiotherapy for medically inoperable lung cancer: Prospective, single-center study of 108 consecutive patients Int J Radiat Oncol Biol Phys 82 2012 967 973
3. J.A. Vargo, R.E. Wegner, and D.E. Heron et al. Stereotactic body radiation therapy for locally recurrent, previously irradiated nonsquamous cell cancers of the head and neck Head Neck 34 2012 1153 1161
4. T. Berghmans, M. Paesmans, and J.P. Sculier Prognostic factors in stage III non-small cell lung cancer: A review of conventional, metabolic and new biological variables Ther Adv Med Oncol 3 2011 127 138
5. J.R. Olsen, C.G. Robinson, and I. El Naqa et al. Dose-response for stereotactic body radiotherapy in early-stage non-small-cell lung cancer Int J Radiat Oncol Biol Phys 81 2011 e299 e303
6. Y. Matsuo, K. Shibuya, and Y. Nagata et al. Prognostic factors in stereotactic body radiotherapy for non-small-cell lung cancer Int J Radiat Oncol Biol Phys 79 2011 1104 1111
7. H.T. Winer-Muram, S.G. Jennings, and R.D. Tarver et al. Volumetric growth rate of stage I lung cancer prior to treatment: Serial CT scanning Radiology 223 2002 798 805
8. T. Murai, Y. Shibamoto, and F. Baba et al. Progression of non-small-cell lung cancer during the interval before stereotactic body radiotherapy Int J Radiat Oncol Biol Phys 82 2012 463 467
9. S. Everitt, A. Herschtal, and J. Callahan et al. High rates of tumor growth and disease progression detected on serial pretreatment fluorodeoxyglucose-positron emission tomography/computed tomography scans in radical radiotherapy candidates with nonsmall cell lung cancer Cancer 116 2010 5030 5037
10. T. Arai, T. Kuroishi, and Y. Saito et al. Tumor doubling time and prognosis in lung cancer patients: Evaluation from chest films and clinical follow-up study Jpn J Clin Oncol 24 1994 199 204
11. K. Usuda, Y. Saito, and M. Sagawa et al. Tumor doubling time and prognostic assessment of patients with primary lung cancer Cancer 74 1994 2239 2244
12. E. Mehrara, E. Forssell-Aronsson, and H. Ahlman et al. Specific growth rate versus doubling time for quantitative characterization of tumor growth rate Cancer Res 67 2007 3970 3975
13. E. Mehrara, E. Forssell-Aronsson, and H. Ahlman et al. Quantitative analysis of tumor growth rate and changes in tumor marker level: Specific growth rate versus doubling time Acta Oncol 48 2009 591 597
14. J.O. Deasy, A.I. Blanco, and V.H. Clark CERR: A computational environment for radiotherapy research Med Phys 30 2003 979 985
15. R.J. Gray A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Statist 16 1988
16. T. Arai, T. Kuroishi, and Y. Saito et al. Tumor doubling time and prognosis in lung cancer patients: Evaluation from chest films and clinical follow-up study. Japanese Lung Cancer Screening Research Group Jpn J Clin Oncol 24 1994 199 204
17. V.P. Collins, R.K. Loeffler, and H. Tivey Observations on growth rates of human tumors Am J Roentgenol Radium Ther Nucl Med 76 1956 988 1000
18. O. Honda, T. Johkoh, and J. Sekiguchi et al. Doubling time of lung cancer determined using three-dimensional volumetric software: Comparison of squamous cell carcinoma and adenocarcinoma Lung Cancer 66 2009 211 217
19. R.M. Lindell, T.E. Hartman, and S.J. Swensen et al. 5-year lung cancer screening experience: Growth curves of 18 lung cancers compared to histologic type, CT attenuation, stage, survival, and size Chest 136 2009 1586 1595
20. M. Petrou, L.E. Quint, and B. Nan et al. Pulmonary nodule volumetric measurement variability as a function of CT slice thickness and nodule morphology AJR Am J Roentgenol 188 2007 306 312